Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system

Area of Science:

• Hepatology
• Virology
• Gastroenterology

Background:

• Chronic persistent hepatitis (CPH) is a common liver condition.
• The prognostic significance of hepatitis B e antigen (HBeAg) in CPH requires further clarification.

Purpose of the Study:

• To evaluate the prognostic implications of HBeAg in patients diagnosed with CPH.
• To determine the association between HBeAg status and disease progression in CPH patients.

Main Methods:

• A cohort of 53 consecutive patients with CPH was studied.
• Patients were categorized based on hepatitis B surface antigen (HBsAg) and HBeAg status.
• Follow-up duration ranged from 12 to 120 months, with a mean of 43 months across all groups.

Main Results:

• Of 16 patients positive for HBsAg and HBeAg, 5 developed chronic active hepatitis (CAH) or cirrhosis.
• Of 9 patients HBsAg positive but HBeAg negative, 1 progressed to CAH.
• Only 2 of 28 HBsAg-negative patients progressed to CAH or cirrhosis.

Conclusions:

• Persistence of HBeAg in CPH patients signifies a serious prognosis.
• HBeAg positivity is associated with a frequent transition to CAH or cirrhosis.
• HBeAg status is a critical marker for predicting long-term outcomes in CPH.